查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519767

2024-2032 年糖尿病護理設備市場報告（按類型（血糖監測設備、胰島素輸送設備）、配銷通路、最終用戶和地區）

Diabetes Care Devices Market Report by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球糖尿病護理設備市場規模達320億美元。糖尿病發病率的上升、技術的快速進步、政府有利舉措的實施、可支配收入的增加、巨量資料和分析的整合以及老年人口的不斷增加是推動市場的一些主要因素。

糖尿病護理設備是指旨在協助監測和管理糖尿病的專用醫療設備。它包括血糖儀、胰島素幫浦、酮測量儀、胰島素筆、自動胰島素傳輸 (AID) 系統和胰島素噴射注射器。糖尿病護理設備廣泛用於血糖自我監測、胰島素劑量、資料追蹤、兒科護理、妊娠糖尿病管理、老年護理、運動計劃、飲食調整和緊急情況。它們是可靠且方便用戶使用的設備，有助於改善血糖控制、堅持治療並最大限度地減少併發症。

可支配收入的增加使更多的人能夠負擔得起複雜的糖尿病護理設備，從而推動了市場的成長。除此之外，由於生活方式的改變，城市地區罹患糖尿病的風險不斷上升，有利於市場的成長。此外，糖尿病護理設備中巨量資料和分析的整合，可以實現更聰明、數據驅動的治療計劃，也有助於市場成長。此外，由於自我監控實踐的日益普及，對方便用戶使用、快速且易於使用的設備的需求不斷成長，這對市場成長產生了積極影響。除此之外，零售平台的激增使消費者能夠以有競爭力的價格輕鬆獲得各種品牌的糖尿病護理設備，這也支持了市場的成長。此外，老年人口數量不斷增加，極易患糖尿病和其他慢性疾病，這是另一個促進生長的因素。

糖尿病護理設備市場趨勢/促進因素：

糖尿病發生率上升

糖尿病盛行率的不斷上升是推動糖尿病護理設備市場的主導因素。這種升級主要是由各種生活方式的改變引起的，包括久坐的習慣以及高糖和高脂肪飲食的消費增加。此外，隨著糖尿病病例數量的增加，對有效管理和監測工具的需求變得比以往任何時候都更加重要。與此一致，糖尿病護理設備被廣泛用於改善血糖管理、最大限度地降低併發症風險、減少緊急醫療就診、提高患者治療效果，並為快速決策提供即時資料。此外，高發生率導致更高的意識和緊迫感，從而鼓勵對研究和創新工作進行更多投資，以加快技術進步的步伐，使市場對潛在買家更具吸引力。

科技的快速進步

快速的技術進步正在塑造糖尿病護理設備市場，這些技術進步提供了更高的精度、易用性和便利性。與此一致的是，連續血糖監測（CGM）系統的引入，提供即時血糖監測，允許更好的治療客製化和生活方式調整，正在對市場成長產生積極影響。此外，配備劑量計算器的智慧胰島素筆的推出，其高度複雜性，從而消除了胰島素劑量的猜測，正在促進市場成長。此外，具有連接功能的創新設備的開發，可實現醫療保健專業人員和患者之間的無縫資料共享，有利於市場成長。

實施有利的政府舉措

公共衛生政策和政府措施在糖尿病護理設備市場的成長中發揮重要作用。一些政府正在認知到糖尿病對醫療保健系統的負擔，並正在採取積極措施來解決這個問題。據此，組織旨在教育公眾有關糖尿病風險和管理的宣傳活動正在促進市場成長。此外，一些政府增加撥款來補貼糖尿病護理設備的成本，使更廣泛的人群更容易獲得這些設備，這也促進了市場的成長。除此之外，引入各種報銷計劃來支付先進設備的成本，例如連續血糖監測（CGM），也促進了市場的成長。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球糖尿病護理設備市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 血糖監測 (BGM) 設備
    • 市場走向
    • 關鍵環節
      • 自我監控設備
      • 連續血糖監測設備
    • 市場預測
  • 胰島素輸送裝置
    • 市場走向
    • 關鍵環節
      • 泵浦
      • 鋼筆
      • 注射器
      • 噴射器
    • 市場預測

第 7 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥局
    • 市場走向
    • 市場預測
  • 糖尿病診所/中心
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 居家護理
    • 市場走向
    • 市場預測
  • 診斷中心
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • ACON Laboratories Inc.
    • Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
    • Becton Dickinson and Company
    • Bionime Corporation
    • Dexcom Inc.
    • F. Hoffmann-La Roche AG
    • Johnson & Johnson
    • Medtronic plc
    • Novo Nordisk A/S
    • Sinocare Inc.
    • Terumo Corporation
Product Code: SR112024A5746

The global diabetes care devices market size reached US$ 32.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 59.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032. The rising incidences of diabetes, rapid technological advancements, imposition of favorable government initiatives, increasing disposable incomes, integration of big data and analytics, and escalating geriatric population are some of the major factors propelling the market.

Diabetes care devices refer to specialized medical equipment designed to assist in the monitoring and management of diabetes. It includes blood glucose meters, insulin pumps, ketone meters, insulin pens, automated insulin delivery (AID) systems, and insulin jet injectors. Diabetes care devices are widely used for self-monitoring of blood glucose, insulin dosing, data tracking, pediatric care, gestational diabetes management, geriatric care, exercise planning, diet modification, and emergency situations. They are reliable and user-friendly devices that aid in improving glucose control, adhering to treatment, and minimizing complications.

The increasing disposable incomes, which are enabling more individuals to afford sophisticated diabetes care devices, are propelling the market growth. Besides this, the rising risk of diabetes across urban areas due to lifestyle changes is favoring the market growth. Additionally, the integration of big data and analytics in diabetes care devices, which allows for smarter, data-driven treatment plans, is contributing to the market growth. Furthermore, the growing demand for user-friendly, quick, and easy-to-use devices, owing to the increasing adoption of self-monitoring practices, is positively influencing the market growth. Apart from this, the proliferation of retail platforms, which allows consumers to easily access diabetes care devices from various brands at competitive prices, is supporting the market growth. Moreover, the escalating geriatric population, which is highly susceptible to diabetes and other chronic illnesses, is acting as another growth-inducing factor.

Diabetes Care Devices Market Trends/Drivers:

The rising incidence of diabetes

The growing prevalence of diabetes is a dominant factor fueling the diabetes care devices market. This escalation is primarily caused by various lifestyle changes, including sedentary habits and increasing consumption of high-sugar and high-fat diets. Furthermore, as the number of diabetes cases multiplies, the need for efficient management and monitoring tools becomes more critical than ever. In line with this, diabetes care devices are widely used to improve glucose management, minimize the risks of complications, reduce emergency healthcare visits, increase patient outcomes, and provide real-time data for quick decision-making. Moreover, the high incidence rates lead to greater awareness and urgency, thereby encouraging more investments in research and innovation efforts to accelerate the pace of technological advancements, making the market even more attractive to potential buyers.

The rapid technological advancements

The diabetes care devices market is being shaped by rapid technological advancements that offer improved precision, ease of use, and convenience. In line with this, the introduction of continuous glucose monitoring (CGM) systems, which provide real-time glucose monitoring, allowing for better treatment customization and lifestyle adjustments, is positively influencing the market growth. Furthermore, the introduction of smart insulin pens equipped with dose calculators, which offer a high level of sophistication, thus eliminating the guesswork in insulin dosing, is contributing to the market growth. Additionally, the development of innovative devices that are equipped with connectivity features, enabling seamless data sharing between healthcare professionals and patients, is favoring the market growth.

The imposition of favorable government initiatives

Public health policies and government initiatives play a significant role in the growth of the diabetes care devices market. Several governments are recognizing the burden that diabetes imposes on healthcare systems and are taking proactive measures to address it. In line with this, the organization of awareness campaigns aimed at educating the public about diabetes risks and management is contributing to the market growth. Moreover, the increasing allocation of funds by several governments to subsidize the cost of diabetes care devices, making them more accessible to a broader population, is contributing to the market growth. Besides this, the introduction of various reimbursement schemes to cover the cost of advanced devices, such as continuous glucose monitoring (CGMs) is contributing to the market growth.

Diabetes Care Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global diabetes care devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, distribution channel and end user.

Breakup by Type:

Blood Glucose Monitoring (BGM) Devices

Self-Monitoring Devices

Continuous Glucose Monitoring Devices

Insulin Delivery Devices

Pumps

Pens

Syringes

Jet Injectors

Blood glucose monitoring (BGM) devices dominate the market

The report has provided a detailed breakup and analysis of the market based on type. This includes blood glucose monitoring (BGM) devices (self-monitoring devices and continuous glucose monitoring devices) and insulin delivery devices (pumps, pens, syringes, and jet injectors). According to the report, blood glucose monitoring (BGM) devices represented the largest segment.

Blood glucose monitoring (BGM) devices are dominating the market as they are highly affordable, making them accessible to a broader range of consumers. Furthermore, they are designed for user-friendliness, often requiring just a small drop of blood for accurate glucose readings. Additionally, BGM devices offer near-instantaneous results, enabling immediate action if needed, such as adjusting insulin dosage or food intake. Besides this, they are compact and easy to carry, making them convenient for people who are always on the go. This portability ensures that monitoring can happen anytime, anywhere. Moreover, BGM devices are being used for a longer period and enjoy broad acceptance among healthcare providers. In addition, they require minimal upkeep, usually replacement of test strips and occasional calibration, which makes them convenient for long-term use.

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Diabetes Clinics/Centers

Online Pharmacies

Others

Hospital pharmacies hold the largest share in the market

A detailed breakup and analysis of the market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, diabetes clinics/Centers, online pharmacies, and others. According to the report, hospital pharmacies accounted for the largest market share.

Hospital pharmacies are dominating the market as they are considered reliable and trustworthy sources for medical devices, including those for diabetes care. Furthermore, patients admitted for diabetes complications or those visiting for a routine check-up can quickly and conveniently purchase the required devices and supplies from the hospital pharmacy. In addition, they employ well-trained pharmacists who can provide expert advice on device usage, thereby adding an extra layer of reassurance for patients. Besides this, products sold in hospital pharmacies are generally subject to rigorous quality checks, ensuring that patients receive authentic and effective devices. Moreover, they offer a streamlined process for insurance claims and reimbursements, making it easier for patients to offset the costs of their diabetes care devices. Along with this, hospital pharmacies offer a comprehensive range of diabetes care devices, giving patients various options to choose from.

Breakup by End User:

Hospitals

Homecare

Diagnostic Centers

Ambulatory Surgery Centers

Hospitals hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, homecare, diagnostic centers, and ambulatory surgery centers. According to the report, hospitals accounted for the largest market share.

Hospitals are dominating the market as they offer a one-stop solution for all medical needs, making it easier for patients to get all their diabetes-related services, including consultations, treatments, and devices. Furthermore, they employ specialists in endocrinology and diabetes care, ensuring that patients receive expert advice and treatment. In addition, hospitals have the resources to handle diabetes-related emergencies, such as diabetic ketoacidosis, which standalone clinics may not be equipped for. Apart from this, hospital-based care is often covered by insurance plans, making it a more accessible option for many patients. Moreover, the sheer number of patients that hospitals serve ensures that they purchase diabetes care devices in bulk, thus contributing to their large share of the market. Along with this, they are subjected to strict quality control standards, which provide assurance of the efficacy and safety of the diabetes care devices used.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest diabetes care devices market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has one of the highest rates of diabetes in the world, which leads to increased demand for diabetes care devices. Furthermore, the region boasts a well-developed healthcare system with widespread availability of advanced medical technologies, including diabetes care devices. Additionally, the presence of comprehensive insurance plans, which cover diabetes treatment and devices, making it convenient for patients to access the care they need, is positively influencing the market growth. Besides this, North America hosts some of the leading companies in medical device manufacturing that are continuously updating and advancing diabetes care technology. In addition, the escalating awareness about diabetes and its management among regional consumers is acting as another growth-inducing factor. Moreover, the imposition of supportive policies and initiatives by regional governments to combat diabetes and provide access to high-quality treatment is favoring the market growth.

Competitive Landscape:

Leading companies are striving to introduce advanced devices, such as smart insulin pens, integrated continuous glucose monitoring (CGM) systems, and more accurate blood glucose meters. Furthermore, they are entering into partnerships with healthcare organizations, tech firms, and even competitors to co-develop new technologies. Besides this, major players are developing customized products to target emerging markets where diabetes is becoming more prevalent. Additionally, they are integrating digital technologies, such as data analytics and telehealth, into their devices to allow real-time monitoring and data collection, which can be crucial for effective diabetes management. Moreover, several companies are investing in education programs and materials to help users understand how to manage diabetes effectively. Along with this, they are leveraging online platforms for direct sales and customer engagement.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

ACON Laboratories Inc.

Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)

Becton Dickinson and Company

Bionime Corporation

Dexcom Inc.

F. Hoffmann-La Roche AG

Johnson & Johnson

Medtronic plc

Novo Nordisk A/S

Sinocare Inc.

Terumo Corporation

Recent Developments:

In February 2020, Abbott Laboratories was granted approval by the U.S. Food and Drug Administration (FDA) to utilize the FreeStyle Libre 14-day Flash glucose monitoring systems within hospital settings.

In April 2021, Medtronic Plc introduced the Medtronic Extended Infusion set in selected European countries, which can be worn for up to 7 days.

In November 2022, Ascensia Diabetes Care Holdings AG announced the integration of the Eversense CGM system with Apple Health.

Key Questions Answered in This Report:

  • How has the global diabetes care devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global diabetes care devices market?
  • What is the impact of each driver, restraint, and opportunity on the global diabetes care devices market?
  • What are the key regional markets?
  • Which countries represent the most attractive diabetes care devices market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the diabetes care devices market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the diabetes care devices market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the diabetes care devices market?
  • What is the competitive structure of the global diabetes care devices market?
  • Who are the key players/companies in the global diabetes care devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Diabetes Care Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Blood Glucose Monitoring (BGM) Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Self-Monitoring Devices
      • 6.1.2.2 Continuous Glucose Monitoring Devices
    • 6.1.3 Market Forecast
  • 6.2 Insulin Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Pumps
      • 6.2.2.2 Pens
      • 6.2.2.3 Syringes
      • 6.2.2.4 Jet Injectors
    • 6.2.3 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diabetes Clinics/Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Online Pharmacies
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostic Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Ambulatory Surgery Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 ACON Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bionime Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Dexcom Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Johnson & Johnson
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Medtronic plc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sinocare Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Diabetes Care Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Diabetes Care Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Diabetes Care Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Diabetes Care Devices Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Diabetes Care Devices Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Diabetes Care Devices Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Diabetes Care Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Diabetes Care Devices (Blood Glucose Monitoring (BGM) Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Diabetes Care Devices (Blood Glucose Monitoring (BGM) Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Diabetes Care Devices (Insulin Delivery Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Diabetes Care Devices (Insulin Delivery Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Diabetes Care Devices (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Diabetes Care Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Diabetes Care Devices (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Diabetes Care Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Diabetes Care Devices (Diabetes Clinics/Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Diabetes Care Devices (Diabetes Clinics/Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Diabetes Care Devices (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Diabetes Care Devices (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Diabetes Care Devices (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Diabetes Care Devices (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Diabetes Care Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Diabetes Care Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Diabetes Care Devices (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Diabetes Care Devices (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Diabetes Care Devices (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Diabetes Care Devices (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Diabetes Care Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Diabetes Care Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Diabetes Care Devices Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Diabetes Care Devices Industry: SWOT Analysis
  • Figure 80: Global: Diabetes Care Devices Industry: Value Chain Analysis
  • Figure 81: Global: Diabetes Care Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Diabetes Care Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Diabetes Care Devices Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Diabetes Care Devices Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Diabetes Care Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Diabetes Care Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Diabetes Care Devices Market: Competitive Structure
  • Table 7: Global: Diabetes Care Devices Market: Key Players